On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program.

Valneva had an agreement in principle with the UK government to provide up to 100 million doses of its SARS-CoV-2 vaccine candidate, to be manufactured at its facilities in Livingston, Scotland. As part of its broader COVID-19 response, Valneva planned to further invest in its manufacturing facility in Livingston, Scotland and Solna, Sweden.